Skip to main content
Top
Published in: General Thoracic and Cardiovascular Surgery 8/2021

01-08-2021 | Stroke | Original Article

Variation in management of post-operative atrial fibrillation (POAF) after thoracic surgery

Authors: Heidi Oi-Yee Li, Heather A. Smith, Olivier Brandts-Longtin, Donna E. Maziak, Sebastien Gilbert, Paul Villeneuve, Sudhir Sundaresan, Andrew J. E. Seely

Published in: General Thoracic and Cardiovascular Surgery | Issue 8/2021

Login to get access

Abstract

Objectives

New-onset post-operative atrial fibrillation (POAF) is a frequent adverse event following major thoracic surgery and is associated with increased risk of perioperative morbidity, length of stay and stroke. It is managed initially with rate and rhythm control therapy; however, optimal duration and the need for anticoagulation are poorly understood. This study aims to assess practice variation regarding POAF management and duration.

Methods

This retrospective, single-center cohort study included patients who underwent major thoracic surgery and developed POAF between 2008 and 2017, managed with rate and rhythm control therapy alone. Demographic, clinical, and surgical variables/outcomes, POAF management, and incidence of POAF recurrence in the 30-day post-operative period were collected. Chi-square and T-tests determined significance.

Results

Of 2054 patients undergoing thoracic surgery, 155 (75%) patients developed POAF. Different rate and rhythm control agents were used, most commonly metoprolol. 107 (69%) continued rate and rhythm control therapy upon hospital discharge for a mean of 56 days. Among the 48 patients with discontinuation of rate and rhythm control therapy on discharge, none demonstrated recurrence of POAF; in contrast to 3 of 107 patients who continued on therapy. Among patients with CHA2DS2-VASc score ≥ 2, 15% were prescribed anticoagulation on discharge.

Conclusions

Use of rate and rhythm control therapy and anticoagulation for POAF is significantly varied in practice. Many patients are not continued on rate and rhythm control after hospital discharge, which does not appear to impact risk of POAF recurrence. Further research to inform guidelines for POAF management, including therapy duration and indications for anticoagulation is warranted.
Appendix
Available only for authorised users
Literature
15.
go back to reference Kowey PR, Stebbins D, Igidbashian L, et al. Clinical outcome of patients who develop PAF after CABG surgery. Pacing Clin Electrophysiol. 2001;24(2):191–3.CrossRef Kowey PR, Stebbins D, Igidbashian L, et al. Clinical outcome of patients who develop PAF after CABG surgery. Pacing Clin Electrophysiol. 2001;24(2):191–3.CrossRef
17.
go back to reference To L, Kalus J, Nemerovski C, Jennings D. Readmission rates in patients with post-operative atrial fibrillation after cardiothoracic surgery and the impact of pharmacotherapy. Pharmacotherapy. 2014;34:E184. To L, Kalus J, Nemerovski C, Jennings D. Readmission rates in patients with post-operative atrial fibrillation after cardiothoracic surgery and the impact of pharmacotherapy. Pharmacotherapy. 2014;34:E184.
Metadata
Title
Variation in management of post-operative atrial fibrillation (POAF) after thoracic surgery
Authors
Heidi Oi-Yee Li
Heather A. Smith
Olivier Brandts-Longtin
Donna E. Maziak
Sebastien Gilbert
Paul Villeneuve
Sudhir Sundaresan
Andrew J. E. Seely
Publication date
01-08-2021
Publisher
Springer Singapore
Published in
General Thoracic and Cardiovascular Surgery / Issue 8/2021
Print ISSN: 1863-6705
Electronic ISSN: 1863-6713
DOI
https://doi.org/10.1007/s11748-020-01574-1

Other articles of this Issue 8/2021

General Thoracic and Cardiovascular Surgery 8/2021 Go to the issue